AKBLF
Price:
$40.65
Market Cap:
$55.40B
Established in 1923 and headquartered in Hørsholm, Denmark, ALK-Abelló A/S is a global pharmaceutical enterprise specializing in allergy treatment. The company provides a comprehensive range of allergy solutions to markets across Europe, North America, and other international regions. These offerings include immunotherapy products delivered through injections, sublingual drops, and oral tablets, designed to address various allergies such as those caused by house dust mites, grass, tree, ragweed, and Japanese cedar. ALK-Abelló also manufactures adrenaline auto-injectors for the critical management of severe allergic reactions and produces diagnostic tools essential for identifying allergic co...[Read more]
Industry
Biotechnology
IPO Date
2009-11-16
Stock Exchange
OTC
Ticker
AKBLF
According to ALK-Abelló A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 54.26B. This represents a change of 19.73% compared to the average of 45.32B of the last 4 quarters.
The mean historical Enterprise Value of ALK-Abelló A/S over the last ten years is 24.34B. The current 54.26B Enterprise Value has changed 22.19% with respect to the historical average. Over the past ten years (40 quarters), AKBLF's Enterprise Value was at its highest in in the December 2025 quarter at 50.03B. The Enterprise Value was at its lowest in in the December 2017 quarter at 7.95B.
Average
24.34B
Median
22.16B
Minimum
8.01B
Maximum
49.82B
Discovering the peaks and valleys of ALK-Abelló A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 62.26%
Maximum Annual Enterprise Value = 49.82B
Minimum Annual Increase = -43.23%
Minimum Annual Enterprise Value = 8.01B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 49.82B | 39.12% |
| 2024 | 35.81B | 57.95% |
| 2023 | 22.67B | 4.69% |
| 2022 | 21.65B | -43.23% |
| 2021 | 38.14B | 36.54% |
| 2020 | 27.94B | 51.03% |
| 2019 | 18.50B | 62.26% |
| 2018 | 11.40B | 42.37% |
| 2017 | 8.01B | -15.84% |
| 2016 | 9.51B | 6.06% |
The current Enterprise Value of ALK-Abelló A/S (AKBLF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
36.10B
5-year avg
33.62B
10-year avg
24.34B
ALK-Abelló A/S’s Enterprise Value is greater than Laboratorios Farmaceuticos Rovi, S.A. (2.98B), greater than Zealand Pharma A/S (16.41B), greater than Shanghai Junshi Biosciences Co., Ltd. (32.71B), greater than InnoCare Pharma Limited (9.61B), greater than Genscript Biotech Corporation (3.72B), greater than Camurus AB (publ) (27.12B), less than Clicks Group Limited (59.99B), greater than Fielmann AG (4.31B), less than Getinge AB (publ) (59.78B), less than COSMOS Pharmaceutical Corporation (495.02B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 2.98B | $4.63B | |
| 16.41B | $3.16B | |
| 32.71B | $4.84B | |
| 9.61B | $2.32B | |
| 3.72B | $3.50B | |
| 27.12B | $3.21B | |
| 59.99B | $3.34B | |
| 4.31B | $4.17B | |
| 59.78B | $5.10B | |
| 495.02B | $2.94B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ALK-Abelló A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ALK-Abelló A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is ALK-Abelló A/S's Enterprise Value?
What is the highest Enterprise Value for ALK-Abelló A/S (AKBLF)?
What is the 3-year average Enterprise Value for ALK-Abelló A/S (AKBLF)?
What is the 5-year average Enterprise Value for ALK-Abelló A/S (AKBLF)?
How does the current Enterprise Value for ALK-Abelló A/S (AKBLF) compare to its historical average?